PET-CT scans could sharpen radiation targeting for liver tumors
NCT ID NCT02088775
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study investigates whether PET-CT scans can accurately measure the radiation dose delivered by radioactive spheres during a liver cancer treatment called radioembolization. Researchers will compare scans taken before and after the procedure in patients with liver tumors. The goal is to see if this imaging method can help doctors plan more effective and safer radiation doses in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radioactive spheres (SIR-Spheres or TheraSphere)
- What this could lead to
- If successful, this approach could help doctors plan more precise radiation doses for liver cancer, potentially improving tumor control while reducing side effects.
- What could go wrong
- This is an observational registry study, not a treatment trial. It may not lead to changes in practice, and results may vary by tumor type or sphere type.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT PRIMARY HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tumor DNA mapping may unlock personalized cancer therapies
- Can a new tracer light up cancer growth?
- Building a biobank to unlock radiation Therapy's secrets
- Experimental drug COH29 targets tumor growth enzyme in advanced cancers
- New registry aims to unlock secrets of cancer in older adults
- New radiation dosing strategy aims to tame large brain metastases